|
|
|
40
|
4331AB
|
SUTENT 12.5MG TAB (PFI/STO) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
3,453.88
|
123.35
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331AB
|
SUTENT 12.5MG TAB (PFI) SUNITINIB (BQ)
|
SUNITINIB
|
SUTENT
|
28'S
|
BQ
|
3453.88
|
123.3527
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AB
|
SUTENT 12.5MG CAP (PFI) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
3,453.88
|
123.35
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331AC
|
SUTENT 25MG TAB (PFI/STO) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
6,792.60
|
242.59
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331AC
|
SUTENT 25MG TAB (PFI) SUNITINIB (BQ)
|
SUNITINIB
|
SUTENT
|
28'S
|
BQ
|
6792.6
|
242.5929
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AC
|
SUTENT 25MG CAP (PFI) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
6,792.60
|
242.59
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AD
|
IMATINIB DENK 100MG TAB (EDK)
|
IMATINIB
|
IMATINIB DENK
|
30'S
|
BQ
|
1,291.20
|
43.04
|
TAB
|
120
|
BLIS
|
EDK
|
DENK PHARMA GMBH & CO. KG.
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331AN
|
XELJANZ 5MG TAB (PFI/STO) TOFACITINIB
|
TOFACITINIB
|
XELJANZ
|
60'S
|
C
|
2,373.42
|
39.56
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331AN
|
XELJANZ 5MG TAB (PFI) TOFACITINIB (C)
|
TOFACITINIB
|
XELJANZ
|
60'S
|
C
|
2373.42
|
39.5571
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AN
|
XELJANZ 5MG TAB (PFI) TOFACITINIB
|
TOFACITINIB
|
XELJANZ
|
60'S
|
C
|
2,373.42
|
39.56
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331BA
|
APO-IMATINIB 100MG TAB (APO) IMATIN (BQ)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
34.52
|
1.1508
|
TAB
|
120
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331BB
|
ZIMITIB 100MG CAP (ZUV) IMATINIB (BQ)
|
IMATINIB
|
ZIMITIB
|
120'S
|
BQ
|
61.76
|
0.5147
|
CAP
|
120
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2024-05-17
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
2024-04-05
|
|
|
|
41
|
4331BD
|
ZIMITIB 100 CAP (ZUV) IMATINIB
|
IMATINIB
|
ZIMITIB
|
30'S
|
BQ
|
47.68
|
1.5893
|
TAB
|
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-05
|
2026-03-31
|
|
ORAL
|
|
ANTINEOPLASTICS
|
2024-04-05
|
|
|
|
40
|
4331E
|
SUTENT 50MG TAB (PFI/STO) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
12,664.1
|
452.29
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331E
|
SUTENT 50MG TAB (PFI) SUNITINIB (BQ)
|
SUNITINIB
|
SUTENT
|
28'S
|
BQ
|
12664.16
|
452.2913
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331E
|
SUTENT 50MG CAP (PFI) SUNITINIB
|
SUNITINIB
|
SUTENT
|
28'S
|
C
|
12,664.16
|
452.29
|
TAB
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331G
|
TASIGNA 150MG CAP (NVS/COL) NILOTANIB
|
NILOTINIB
|
TASIGNA
|
112'S
|
C
|
11,490.9
|
102.60
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331G
|
TASIGNA 150MG CAP (NVS) NILOTANIB (BQ)
|
NILOTINIB
|
TASIGNA
|
112'S
|
BQ
|
7611.31
|
67.9581
|
CAP
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331G
|
TASIGNA 150MG CAP (NVS) NILOTANIB
|
NILOTINIB
|
TASIGNA
|
112'S
|
C
|
7,611.31
|
67.96
|
CAP
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331L
|
AFINITOR 5MG TAB (NVS/COL) EVEROLIMUS
|
EVEROLIMUS
|
AFINITOR
|
30'S
|
C
|
5,436.65
|
181.22
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|